Capricor Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $11,130 | $2,261 | $3,971 | $4,906 |
Gross Profit | -3,424 | 2,261 | 3,614 | 4,575 |
EBITDA | -7,336 | -12,648 | -11,234 | -9,934 |
EBIT | -7,697 | -13,009 | -11,591 | -10,265 |
Net Income | -7,116 | -12,556 | -10,999 | -9,794 |
Net Change In Cash | 11,130 | 2,261 | 3,971 | 4,906 |
Free Cash Flow | -15,531 | -11,701 | -12,369 | -1,932 |
Cash | 11,286 | 68,377 | 10,688 | 6,214 |
Basic Shares | 44,509 | 33,090 | 31,841 | 31,354 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $22,270 | $25,178 | $2,548 | $244 |
Gross Profit | -27,698 | 24,109 | 1,854 | |
EBITDA | -41,165 | -23,008 | -29,164 | -20,692 |
EBIT | -42,564 | -24,077 | -29,859 | -20,938 |
Net Income | -40,467 | -22,287 | -29,018 | -19,409 |
Net Change In Cash | 22,270 | 25,178 | 2,548 | 244 |
Cost of Revenue | -25,282 | 2,219 | ||
Free Cash Flow | -41,534 | -27,644 | 1,556 | -18,005 |
Cash | 11,286 | 14,694 | 9,603 | 34,885 |
Basic Shares | 35,218 | 26,778 | 24,552 | 23,089 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.16 |
2024-09-30 | -$0.38 |
2024-06-30 | -$0.35 |
2024-03-31 | -$0.31 |
